INS and diabetes mellitus: Individuals with SAID most frequently had insulin treatment, particularly among those with the long-term diabetes (84.1 and 58.8%), while oral antidiabetic treatment was more frequent in the new-onset group (9.4 and 27.5%) (Supplementary Table 1).